HM Payson & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $489K | Buy |
7,041
+2,600
| +59% | +$181K | 0.01% | 285 |
|
|
2024
Q4 | $382K | Buy |
4,441
+316
| +8% | +$27.2K | 0.01% | 317 |
|
|
2024
Q3 | $491K | Buy |
4,125
+150
| +4% | +$17.9K | 0.01% | 287 |
|
|
2024
Q2 | $567K | Buy |
3,975
+105
| +3% | +$15K | 0.01% | 260 |
|
|
2024
Q1 | $497K | Sell |
3,870
-56
| -1% | -$7.19K | 0.01% | 287 |
|
|
2023
Q4 | $406K | Hold |
3,926
| – | – | 0.01% | 294 |
|
|
2023
Q3 | $357K | Hold |
3,926
| – | – | 0.01% | 300 |
|
|
2023
Q2 | $318K | Sell |
3,926
-28
| -0.7% | -$2.27K | 0.01% | 312 |
|
|
2023
Q1 | $315K | Buy |
3,954
+28
| +0.7% | +$2.23K | 0.01% | 309 |
|
|
2022
Q4 | $266K | Buy |
3,926
+56
| +1% | +$3.79K | 0.01% | 328 |
|
|
2022
Q3 | $193K | Sell |
3,870
-4
| -0.1% | -$199 | 0.01% | 368 |
|
|
2022
Q2 | $216K | Buy |
3,874
+4
| +0.1% | +$223 | 0.01% | 362 |
|
|
2022
Q1 | $215K | Hold |
3,870
| – | – | ﹤0.01% | 387 |
|
|
2021
Q4 | $217K | Sell |
3,870
-76
| -2% | -$4.26K | ﹤0.01% | 387 |
|
|
2021
Q3 | $189K | Hold |
3,946
| – | – | ﹤0.01% | 396 |
|
|
2021
Q2 | $165K | Buy |
3,946
+410
| +12% | +$17.1K | ﹤0.01% | 415 |
|
|
2021
Q1 | $119K | Sell |
3,536
-576
| -14% | -$19.4K | ﹤0.01% | 461 |
|
|
2020
Q4 | $144K | Buy |
4,112
+3,312
| +414% | +$116K | ﹤0.01% | 432 |
|
|
2020
Q3 | $28K | Sell |
800
-4,000
| -83% | -$140K | ﹤0.01% | 675 |
|
|
2020
Q2 | $157K | Sell |
4,800
-1,100
| -19% | -$36K | 0.01% | 376 |
|
|
2020
Q1 | $178K | Buy |
5,900
+400
| +7% | +$12.1K | 0.01% | 339 |
|
|
2019
Q4 | $159K | Hold |
5,500
| – | – | 0.01% | 422 |
|
|
2019
Q3 | $142K | Hold |
5,500
| – | – | 0.01% | 438 |
|
|
2019
Q2 | $140K | Buy |
+5,500
| New | +$140K | 0.01% | 448 |
|
|
2016
Q3 | – | Sell |
-8,190
| Closed | -$221K | – | 328 |
|
|
2016
Q2 | $221K | Buy |
+8,190
| New | +$221K | 0.01% | 303 |
|